# Tirzepatide in the Treatment of Cannabis Use Disorder

> **NCT07671248** · PHASE3 · NOT_YET_RECRUITING · sponsor: **McMaster University** · enrollment: 15 (estimated)

## Conditions studied

- Cannabis Use Disorder, Moderate
- Cannabis Use Disorder, Severe

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07671248
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671248, "Tirzepatide in the Treatment of Cannabis Use Disorder". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*